Initial Dose of Three Monthly Intravitreal Injections Versus PRN Intravitreal Injections of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
BioMed Research International - United States
doi 10.1155/2013/209735
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Hindawi Limited